Health ❯ Cancer

Oncology

Treatment Patient Care Early-Onset Cancer Patient Advocacy Drug Development Patient Support KRAS Mutations Tumor Biology Research and Development Research Emotional Well-being Therapies Public Health Triple Negative Breast Cancer Clinical Research Tumor Microenvironment Cancer Centers Screening Mortality Psychological Support Therapeutics Statistics Patient Stories Oncologists Early Detection Patient Experience Tumorigenesis Drug Therapies Cancer Research

Merck Ends Revolution Medicines Takeover Talks After Valuation Standoff

Interest centered on Revolution’s late-stage pan‑RAS drug daraxonrasib, a key driver of the biotech’s standalone prospects.

Aktis Oncology Soars 24% in Nasdaq Debut After $318 Million IPO

Global Study Finds Obesity-Linked Cancers Rising in Young and Older Adults, With Colorectal Climbing Fastest in the Young

Single-Cell Analysis Reveals Fallopian Tube Changes Linked to Ovarian Cancer Risk